JP6258409B2 - ムベ抽出物を含む医薬組成物 - Google Patents
ムベ抽出物を含む医薬組成物 Download PDFInfo
- Publication number
- JP6258409B2 JP6258409B2 JP2016116887A JP2016116887A JP6258409B2 JP 6258409 B2 JP6258409 B2 JP 6258409B2 JP 2016116887 A JP2016116887 A JP 2016116887A JP 2016116887 A JP2016116887 A JP 2016116887A JP 6258409 B2 JP6258409 B2 JP 6258409B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- composition
- antipyretic
- inflammatory
- fraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Immunology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
Description
1−1.ムベ抽出物の製造
ムベ(Stauntonia hexaphylla)葉の熱水抽出物は、ムベ葉10kgを熱水を用いて110℃で図1に示すような熱水抽出法を行って製造した。また、ムベ果実の熱水抽出物は、ムベ果実2,100gを熱水40Lを用いて100℃で図2に示すような熱水抽出法を行って製造した。
ムベ葉の熱水抽出物及びムベ果実の熱水抽出物の分画物を製造することは図1または図2に示した製造方法によって行った。
前記実施例1で製造されたムベ葉の熱水抽出物、ムベ果実の熱水抽出物、及びムベ葉の熱水抽出物の分画物の細胞毒性を測定するために、マウスの大食細胞であるRAW264.7細胞をATCCで購入して利用した。
前記実施例1で製造されたムベ葉の抽出物及び分画物の抗炎効果を確認するために、前記実施例2で培養したRAW264.7細胞を使用した。
前記実施例3でNO分泌量により抗炎効果に優れたと確認されたムベ葉の熱水抽出物の抗炎効果を再び確認するために、炎症反応に関連したサイトカイン(cytokine)、具体的にiNOSのmRNA含量の変化を大食細胞(Macrophage primary cell)を用いて確認した。
前記実施例3及び実施例4でNO分泌量及びiNOSのmRNA含量の減少効果から、抗炎効果に優れたと確認されたムベ葉の熱水抽出物の抗炎効果を再び確認するために、iNOS及びCOX2発現抑制活性を確認した。
前記実施例1で製造されたムベ果実の熱水抽出物の抗炎効果を確認するために、炎症反応に関連したサイトカイン(cytokine)のmRNA含量の変化を大食細胞(Macrophage primary cell)を用いて確認した。
前記実施例6で炎症反応に関連したサイトカイン(cytokine)のmRNA含量の変化から、抗炎効果に優れていると確認されたムベ果実の熱水抽出物の抗炎効果を再び確認するために、炎症反応に関連したサイトカイン(cytokine)のうち、TNF−αの変化を大食細胞(Macrophage primary cell)を用いて確認した。
前記実施例3でNO分泌量により抗炎効果に優れたことが確認されたムベ葉の熱水抽出物の分画物の抗炎効果を再び確認するために、COX−2酵素阻害活性を確認した。
9−1.ムベ葉の抽出物の解熱効果の確認
前記実施例1で製造されたムベ葉の抽出物及び分画物の解熱効果を確認するために、実験動物を利用した。
前記実施例1−2で製造されたムベ葉の抽出物の分画物の解熱効果を確認するために、前記実施例9−1の方法で飼育された実験動物(5週齢のSD雄白ラット((株)SAMTAKO社、大韓民国))を利用した。
Claims (8)
- ムベ(Stauntonia Hexaphylla)葉抽出物を有効成分として含むことを特徴とする抗炎組成物。
- ムベ(Stauntonia Hexaphylla)葉抽出物を有効成分として含むことを特徴とする炎症疾患治療及び予防用薬学組成物。
- 前記炎症疾患は、皮膚炎、皮膚筋炎(dermatomyositis)、多発性筋炎(polymyositis)、アレルギー、全身性紅斑性狼瘡、天疱瘡、アフター性口内炎、網膜炎、胃炎、肝炎、気管支炎、食道炎、腸炎、膵臓炎、大膓炎、腎臓炎、床擦れ、狼瘡、慢性甲状腺炎、多発性硬化症、敗血症(sepsis)、放射線損傷、臓器移植の拒絶反応、全身性浮腫及び局所性浮腫からなる群から選択される何れか1つであることを特徴とする請求項2に記載の炎症疾患治療及び予防用薬学組成物。
- ムベ(Stauntonia Hexaphylla)葉抽出物を有効成分として含むことを特徴とする炎症緩和または改善用化粧料組成物。
- ムベ(Stauntonia Hexaphylla)葉抽出物を有効成分として含むことを特徴とする解熱用組成物。
- 前記解熱用組成物は解熱剤または解熱鎮痛剤であることを特徴とする請求項5に記載の解熱用組成物。
- ムベ葉を水、炭素数1〜5のアルコール及びその混合物からなる群から選択される1種以上を抽出溶媒として抽出して得られたムベ抽出物を、有効成分として添加することを特徴とする抗炎組成物の製造方法。
- ムベ葉を水、炭素数1〜5のアルコール及びその混合物からなる群から選択される1種以上を抽出溶媒として抽出して得られたムベ抽出物を、有効成分として添加することを特徴とする解熱用組成物の製造方法。
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110082023A KR101167589B1 (ko) | 2011-08-18 | 2011-08-18 | 멀꿀 열매 추출물을 포함하는 항염증제 |
KR10-2011-0082023 | 2011-08-18 | ||
KR10-2012-0038977 | 2012-04-16 | ||
KR1020120038977A KR101221617B1 (ko) | 2012-04-16 | 2012-04-16 | 멀꿀 잎 추출물을 포함하는 항염증제 |
KR1020120050532A KR101243115B1 (ko) | 2012-04-17 | 2012-05-11 | 멀꿀 잎 추출물을 포함하는 해열제 |
KR10-2012-0050532 | 2012-05-11 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014525911A Division JP6049721B2 (ja) | 2011-08-18 | 2012-05-16 | ムベ抽出物を含む医薬組成物 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2016164202A JP2016164202A (ja) | 2016-09-08 |
JP2016164202A5 JP2016164202A5 (ja) | 2016-12-15 |
JP6258409B2 true JP6258409B2 (ja) | 2018-01-10 |
Family
ID=50185141
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014525911A Active JP6049721B2 (ja) | 2011-08-18 | 2012-05-16 | ムベ抽出物を含む医薬組成物 |
JP2016116887A Active JP6258409B2 (ja) | 2011-08-18 | 2016-06-13 | ムベ抽出物を含む医薬組成物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014525911A Active JP6049721B2 (ja) | 2011-08-18 | 2012-05-16 | ムベ抽出物を含む医薬組成物 |
Country Status (9)
Country | Link |
---|---|
US (2) | US9370542B2 (ja) |
EP (2) | EP2774617B1 (ja) |
JP (2) | JP6049721B2 (ja) |
CN (2) | CN103826651A (ja) |
AU (2) | AU2012295779A1 (ja) |
CA (2) | CA2999174C (ja) |
ES (2) | ES2620022T3 (ja) |
PL (2) | PL2774617T3 (ja) |
WO (1) | WO2013024960A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101532832B1 (ko) * | 2013-06-30 | 2015-06-30 | 재단법인 전남생물산업진흥원 | 멀꿀 잎 추출물을 유효성분으로 포함하는 골조직 생성 촉진용 약학 조성물 |
US10137162B1 (en) * | 2018-01-26 | 2018-11-27 | King Saud University | Gastroprotective extracts of Sonchus oleraceus L. |
CN114053296A (zh) * | 2021-11-28 | 2022-02-18 | 赣州安宏环保科技有限公司 | 近视眼提升视力的明目效果纳米气化胶及其制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01242596A (ja) * | 1988-03-17 | 1989-09-27 | Zhongguo Yixuekexueyuan Yaowo Yanjiusuo | リグナン化合物 |
JPH01290694A (ja) * | 1988-05-07 | 1989-11-22 | Zhongguo Yixuekexueyuan Yaowo Yanjiusuo | リグナン化合物 |
JP2001226249A (ja) * | 2000-02-17 | 2001-08-21 | Ichimaru Pharcos Co Ltd | 植物水蒸気蒸留水含有化粧料組成物 |
CN1562275A (zh) * | 2004-03-22 | 2005-01-12 | 广州安健实业发展有限公司 | 野木瓜总甙及其注射剂 |
CN1742816A (zh) * | 2005-10-07 | 2006-03-08 | 张益群 | 一种五角枫根外用药 |
CN100350932C (zh) * | 2005-12-27 | 2007-11-28 | 王赛 | 非手术治疗鼻炎、咽喉炎的药物 |
CN101024065A (zh) * | 2007-04-09 | 2007-08-29 | 林水文 | 一种活络油的药物组合物及其制备方法 |
CN101283784B (zh) * | 2007-09-27 | 2012-01-11 | 贵州大学 | 野木瓜保健固体饮料及其制备方法 |
KR100906696B1 (ko) * | 2007-11-12 | 2009-07-07 | 이스트힐(주) | 오메가오일과 멀꿀나무 추출물을 포함하는 색조 화장료용 복합 분체 |
CN101879196A (zh) * | 2009-05-08 | 2010-11-10 | 何国增 | 一种中药野木瓜注射液的制备方法 |
KR101326158B1 (ko) * | 2009-12-15 | 2013-11-06 | 재단법인 제주테크노파크 | 항히스타민제 조성물 |
CN102132914A (zh) | 2010-01-27 | 2011-07-27 | 遵义光勋绿色产业有限公司 | 一种野木瓜饮料的制备方法 |
CN101926488B (zh) * | 2010-04-06 | 2012-05-23 | 贵州大学 | 一种野木瓜果醋饮料的制备方法 |
-
2012
- 2012-05-16 CA CA2999174A patent/CA2999174C/en active Active
- 2012-05-16 CA CA2845625A patent/CA2845625C/en active Active
- 2012-05-16 JP JP2014525911A patent/JP6049721B2/ja active Active
- 2012-05-16 WO PCT/KR2012/003867 patent/WO2013024960A1/ko active Application Filing
- 2012-05-16 ES ES12824322.7T patent/ES2620022T3/es active Active
- 2012-05-16 PL PL12824322T patent/PL2774617T3/pl unknown
- 2012-05-16 ES ES16176916T patent/ES2752249T3/es active Active
- 2012-05-16 EP EP12824322.7A patent/EP2774617B1/en active Active
- 2012-05-16 PL PL16176916T patent/PL3097920T3/pl unknown
- 2012-05-16 CN CN201280045043.0A patent/CN103826651A/zh active Pending
- 2012-05-16 US US14/239,521 patent/US9370542B2/en active Active
- 2012-05-16 AU AU2012295779A patent/AU2012295779A1/en not_active Abandoned
- 2012-05-16 CN CN201810231572.9A patent/CN108392501A/zh active Pending
- 2012-05-16 EP EP16176916.1A patent/EP3097920B1/en active Active
-
2016
- 2016-02-01 US US15/012,553 patent/US20160193265A1/en not_active Abandoned
- 2016-03-23 AU AU2016201841A patent/AU2016201841B2/en active Active
- 2016-06-13 JP JP2016116887A patent/JP6258409B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
AU2012295779A1 (en) | 2014-03-06 |
EP2774617A4 (en) | 2015-02-18 |
JP2014524436A (ja) | 2014-09-22 |
EP2774617B1 (en) | 2016-12-21 |
JP2016164202A (ja) | 2016-09-08 |
CA2999174A1 (en) | 2013-02-21 |
ES2620022T3 (es) | 2017-06-27 |
JP6049721B2 (ja) | 2016-12-21 |
WO2013024960A1 (ko) | 2013-02-21 |
CN103826651A (zh) | 2014-05-28 |
CN108392501A (zh) | 2018-08-14 |
EP3097920B1 (en) | 2019-07-31 |
CA2845625C (en) | 2018-05-15 |
EP3097920A1 (en) | 2016-11-30 |
ES2752249T3 (es) | 2020-04-03 |
US9370542B2 (en) | 2016-06-21 |
PL2774617T3 (pl) | 2017-08-31 |
AU2016201841A1 (en) | 2016-05-19 |
AU2016201841B2 (en) | 2017-11-02 |
EP2774617A1 (en) | 2014-09-10 |
CA2845625A1 (en) | 2013-02-21 |
PL3097920T3 (pl) | 2020-03-31 |
US20160193265A1 (en) | 2016-07-07 |
CA2999174C (en) | 2020-07-14 |
US20140205691A1 (en) | 2014-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101221617B1 (ko) | 멀꿀 잎 추출물을 포함하는 항염증제 | |
JP6258409B2 (ja) | ムベ抽出物を含む医薬組成物 | |
KR101167589B1 (ko) | 멀꿀 열매 추출물을 포함하는 항염증제 | |
KR20190064714A (ko) | 레몬머틀 추출물을 유효성분으로 포함하는 항염증제 | |
KR101317668B1 (ko) | 멀꿀 잎 추출물을 유효성분으로 포함하는 관절염 치료 또는 예방용 약학 조성물 | |
KR20170069050A (ko) | 다슬기 가수분해물을 유효성분으로 포함하는 항염증제 | |
KR101403396B1 (ko) | 개꼬시래기 아임계수 추출물을 유효성분으로 포함하는 항염증제 | |
KR20170000491A (ko) | 곰보배추 추출물, 느릅나무 추출물, 노나무 추출물 및 가시오가피 추출물을 유효성분으로 포함하는 알레르기성 비염 예방 및 코막힘 치료용 조성물 | |
KR20160069919A (ko) | 삼채 추출물을 포함하는 항염증제 | |
KR101702621B1 (ko) | 꽃잔디 추출물을 포함하는 항염증제 | |
KR20190038702A (ko) | 다시마 발효물을 유효성분으로 포함하는 항염증제 | |
KR102258283B1 (ko) | 천연물 발효 복합추출물을 유효성분으로 포함하는 염증 또는 알레르기 치료 및 개선용 조성물 및 이의 제조방법 | |
KR20190001163A (ko) | 울금 발효물을 유효성분으로 포함하는 항염증제 | |
KR102209969B1 (ko) | 절패모의 추출물을 함유하는 아토피 예방 또는 치료용 조성물 | |
KR20130032995A (ko) | 타마린드 추출물을 유효성분으로 포함하는 항염증 활성을 갖는 조성물 | |
CN106456685A (zh) | 包含高山蒿提取物的组合物 | |
KR102480364B1 (ko) | 피부 상태 개선용 화장료 조성물 및 이의 제조방법 | |
KR101185903B1 (ko) | 등골나물 추출물을 포함하는 항염증제 | |
KR102681194B1 (ko) | 황벽나무 추출물을 포함하는 피부 당화 억제용 화장료 조성물 | |
KR102142060B1 (ko) | 소목 초단파 추출물을 포함하는 항염증제 | |
KR20240044148A (ko) | 모링가 잎, 창포 전초 및 구기자 열매의 발효 추출물을 유효성분으로 포함하는 항산화 또는 항염증용 화장료 조성물 | |
CN106535910A (zh) | 包含大星芹提取物的组合物 | |
KR20130013693A (ko) | 창포 추출물을 유효성분으로 포함하는 아토피 피부염 예방 및 개선용 외용 조성물 | |
KR20130099764A (ko) | 도금양 추출물을 유효성분으로 포함하는 염증질환 예방 및 치료용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160713 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161027 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170328 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170628 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170801 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171030 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20171114 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20171206 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6258409 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |